leisure time -WSS

leisure time

author：explore 2025-09-27 17:03:16 - browse：94364

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Is it ever OK for doctors to lie to their patients?

WSS

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

At Orexo, a ‘turning point’ for everything but digital health

FDA approves RSV monoclonal antibody for infants, toddlers

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Warren pushes Witty on UnitedHealth's control over physicians

Listen: Wegovy in the brain & pivotal Alzheimer's data

hotspot

leisure time

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

In early work, researchers turn to CRISPR to treat Alzheimer's

In age of alternative facts, a scholarly course on calling out crap

Novel spinal cord stimulator treats paralysis without surgery

At least 13 dead in Texas as scorching temps continue

Listen: Wegovy in the brain & pivotal Alzheimer's data

Hepatitis C has a cure — but many Americans still lack access to it

As digital health tech proliferates, a new institute aims to cut through hype

Cancer drug shortages should be causing more outrage

FDA approves RSV monoclonal antibody for infants, toddlers

knowledge

The effects of a landmark ruling on DNA ownership are becoming clearer

Brain technologies pose threats that are all too real, experts warn

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Black vets could get higher VA benefits if race not used in lung test

As billionaires fund anti

How Medicaid coverage policies for immigrants impact new moms

hotspot

knowledge

knowledge

focus